Home / Companies / Aizant Drug Research Solutions Pvt Ltd., Clinical Pharmacology Unit-II

Aizant Drug Research Solutions Pvt Ltd., Clinical Pharmacology Unit-II FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

Latest inspection NAI · Apr 28, 2022
No warning letters matched by name

Inspections 2

0 OAI

Recalls 0 0 Class I

Warning letters 0 None on file

510(k) clearances 0 None on file

Aizant Drug Research Solutions Pvt Ltd., Clinical Pharmacology Unit-II has 0 FDA recalls, 2 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Aizant Drug Research Solutions Pvt Ltd., Clinical Pharmacology Unit-II" is on file.

What these totals cover: FDA records filed under the name "Aizant Drug Research Solutions Pvt Ltd., Clinical Pharmacology Unit-II".

Latest inspection: Apr 28, 2022 · NAI

Summary

Record counts and when each FDA source was last refreshed
Records	Count	Last refreshed	Source as of	Status
Recalls	0	Nov 11, 2026 (checked Nov 15, 2026, unchanged)	File dated Nov 10, 2026	Current
510(k) clearances	0	Nov 15, 2026	File dated Nov 9, 2026	Current
Inspections	2	Nov 15, 2026	Newest record Nov 5, 2026	Current
Compliance actions	0	Nov 2, 2026	Newest record Oct 29, 2026	Current

FDA record by year

Aizant Drug Research Solutions Pvt Ltd., Clinical Pharmacology Unit-II's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Aizant Drug Research Solutions Pvt Ltd., Clinical Pharmacology Unit-II: FDA inspections per year

Year	Inspections	OAI	Warning letters	Recall records	Class I
2026	0	0	0	0	0
2025	0	0	0	0	0
2024	0	0	0	0	0
2023	0	0	0	0	0
2022	1	0	0	0	0
2021	0	0	0	0	0
2020	0	0	0	0	0
2019	0	0	0	0	0
2018	1	0	0	0	0
2017	0	0	0	0	0

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Aizant Drug Research Solutions Pvt Ltd., Clinical Pharmacology Unit-II as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Aizant Drug Research Solutions Pvt Ltd., Clinical Pharmacology Unit-II yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent FDA inspections

2 inspections from Sep 21, 2018 to Apr 28, 2022.

Date	Site	Product	Classification	FEI
Apr 28, 2022	Hyderabad, India	Drugs	No Action Indicated (NAI)	3014725464
Sep 21, 2018	Hyderabad, India	Drugs	No Action Indicated (NAI)	3014725464

NAI: No objectionable conditions or practices were found during the inspection.
VAI: Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI: Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

Facility	Location	Inspections	Latest
FEI 3014725464	Hyderabad, India	2	Apr 28, 2022

Aizant Drug Research Solutions Pvt Ltd., Clinical Pharmacology Unit-II and the FDA: common questions

Has Aizant Drug Research Solutions Pvt Ltd., Clinical Pharmacology Unit-II received an FDA warning letter?

No FDA warning letter addressed to the name "Aizant Drug Research Solutions Pvt Ltd., Clinical Pharmacology Unit-II" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Aizant Drug Research Solutions Pvt Ltd., Clinical Pharmacology Unit-II received an FDA Form 483?

FDA has not published a Form 483 for "Aizant Drug Research Solutions Pvt Ltd., Clinical Pharmacology Unit-II" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Aizant Drug Research Solutions Pvt Ltd., Clinical Pharmacology Unit-II?

The most recent FDA inspection on file ended Apr 28, 2022 at Hyderabad, India and was classified NAI. FDA has 2 inspections of Aizant Drug Research Solutions Pvt Ltd., Clinical Pharmacology Unit-II on file.

Need more than this page shows? Ask about Aizant Drug Research Solutions Pvt Ltd., Clinical Pharmacology Unit-II in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.